The effect MYC has on glycolysis is highly variable depending on the cancer type, with a MYC-associated increase in non-small cell lung cancer and hepatocellular carcinoma, and a MYC associated decrease in renal cell carcinoma and prostatic intraepithelial neoplasia. Here, MYC is linked to prostate intraepithelial neoplasia.